1BENTZEN H, PEDERSEN R S, PEDERSEN H B, et al. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretie peptide in heart failure[J] . Clin Sci(Lond), 2003, 104(3):303 - 312.
2KYRIAKIDES Z S, MARKIANOS M,MICHALIS L, et el. Brain natriurotic peptide increase acutely and much more prominendy than atriel during coronary angioplasty [J]. Clin Cardiol, 2000, 23(4): 285 - 288.
3TATEISHI J, MASUTANI M, OHYANAGI M, et al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty [J]. Clin Cardiol,2000, 23(10) : 776 - 780.
4WAKU S, IIDA N. Significance of brain natriuretic peptide measurement as a diagnostic indicator of cardiac function [J].Methods Inf Med, 2000, 39(3): 976-982.
5REDFIELD M M, RODEHEFFER R J,JACOBSEN S J, et al. Plasma brain natriuretic peptide concentration: impact ofage and gender [J]. J Am Coil Cardiol,2002, 40 (5) : 976 - 982.
6LUCHNER A, MUDERS F, DIETL O, et al. Differential of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction [J]. Cardiovasc Res, 2001, 51(3): 601 -607.
7MAISEL A S, KOON J, KRISHNASWAMY P, et al. Utility of B- natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction [J].Am Heart J, 2001, 141 (3): 367 - 374.
8TROUGHTON R W, FRAMPTON C M,YANDLE T G, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide concentrations[J]. Lancet, 2000, 355(9210): 1126-1130.
9OMLAND T, PEBSSON A, NG L, et al.N-terminal pro-B-type natriurctic peptide and long-term mortality in acute coronary syndromes [J]. Circulation, 2002, 106(23): 2913 - 2918.
10CASCO V H, VEINOT J P, KUROSKI dE BOLD M L, et al. Natriuretic peptide system gene expression human coronary arteries [J]. J Histochem Cytochem, 2002,50(6): 799 - 809.
